Found: 36
Select item for more details and to access through your institution.
Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2022.954093
- By:
- Publication type:
- Article
Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.836449
- By:
- Publication type:
- Article
Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e888, doi. 10.1093/cid/ciab938
- By:
- Publication type:
- Article
Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 7, p. 1158, doi. 10.1093/cid/ciab616
- By:
- Publication type:
- Article
Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 10, p. 1754, doi. 10.1093/cid/ciy876
- By:
- Publication type:
- Article
The relationship between anti-spike SARS-CoV-2 antibody levels and risk of breakthrough COVID-19 among fully vaccinated adults.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 3, p. 485, doi. 10.1093/infdis/jiac023
- By:
- Publication type:
- Article
Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 1, p. 11, doi. 10.1093/infdis/jiac023
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016-2017 and 2017-2018 Epidemics in Canada.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Nasopharyngeal angiotensin converting enzyme 2 (ACE2) expression as a risk-factor for SARS-CoV-2 transmission in concurrent hospital associated outbreaks.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-024-09067-9
- By:
- Publication type:
- Article
Factors associated with SARS-CoV-2 infection in unvaccinated children and young adults.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-023-08950-1
- By:
- Publication type:
- Article
Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January-April 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness?
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 9, p. N.PAG, doi. 10.1093/ofid/ofy211
- By:
- Publication type:
- Article
Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada.
- Published in:
- Eurosurveillance (15607917), 2022, v. 27, n. 38, p. 2, doi. 10.2807/1560-7917.ES.2022.27.38.2200720
- By:
- Publication type:
- Article
Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020.
- Published in:
- Eurosurveillance (15607917), 2020, v. 25, n. 7, p. 2, doi. 10.2807/1560-7917.es.2020.25.7.2000103
- By:
- Publication type:
- Article
Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).
- Published in:
- Eurosurveillance (15607917), 2019, v. 24, n. 46, p. 1, doi. 10.2807/1560-7917.ES.2019.24.46.1900585
- By:
- Publication type:
- Article
Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: possible cohort effect following the 2009 influenza pandemic.
- Published in:
- Eurosurveillance (15607917), 2019, v. 24, n. 15, p. 32, doi. 10.2807/1560-7917.ES.2019.24.15.1900104
- By:
- Publication type:
- Article
Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.
- Published in:
- Eurosurveillance (15607917), 2018, v. 23, n. 5, p. 2, doi. 10.2807/1560-7917.ES.2018.23.5.18-00035
- By:
- Publication type:
- Article
Descriptive Epidemiology and Phylodynamics of the "First Wave" of an Outbreak of Highly Pathogenic Avian Influenza (H5N1 Clade 2.3.4.4b) in British Columbia and the Yukon, Canada, April to September 2022.
- Published in:
- Transboundary & Emerging Diseases, 2024, v. 2024, p. 1, doi. 10.1155/2024/2327939
- By:
- Publication type:
- Article
Respiratory virus surveillance after the height of the COVID-19 pandemic.
- Published in:
- British Columbia Medical Journal, 2024, v. 66, n. 6, p. 216
- By:
- Publication type:
- Article
Monkeypox: What primary care providers need to know about testing.
- Published in:
- British Columbia Medical Journal, 2022, v. 64, n. 8, p. 357
- By:
- Publication type:
- Article
Advances in HIV serology: Implications for clinical care.
- Published in:
- British Columbia Medical Journal, 2017, v. 59, n. 10, p. 499
- By:
- Publication type:
- Article
Increased mumps activity in BC and across North America.
- Published in:
- British Columbia Medical Journal, 2017, v. 59, n. 5, p. 272
- By:
- Publication type:
- Article
Two‐phase Bayesian latent class analysis to assess diagnostic test performance in the absence of a gold standard: COVID‐19 serological assays as a proof of concept.
- Published in:
- Vox Sanguinis, 2023, v. 118, n. 12, p. 1069, doi. 10.1111/vox.13545
- By:
- Publication type:
- Article
Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008–2019.
- Published in:
- PLoS ONE, 2020, v. 15, n. 12, p. 1, doi. 10.1371/journal.pone.0244575
- By:
- Publication type:
- Article
Investigation of aminoglycoside resistance inducing conditions and a putative AmrAB-OprM efflux system in Burkholderia vietnamiensis.
- Published in:
- Annals of Clinical Microbiology & Antimicrobials, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-0711-13-2
- By:
- Publication type:
- Article
Influence of chronic hepatitis C infection on the monocyte-to-platelet ratio: data analysis from the National Health and Nutrition Examination Survey (2009-2016).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Influenza Classification Suite: An automated Galaxy workflow for rapid influenza sequence analysis.
- Published in:
- Influenza & Other Respiratory Viruses, 2020, v. 14, n. 3, p. 358, doi. 10.1111/irv.12722
- By:
- Publication type:
- Article
HIV serology signal-to-cutoff ratio as a rapid method to predict confirmation of HIV infection.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2018, v. 37, n. 8, p. 1589, doi. 10.1007/s10096-018-3290-y
- By:
- Publication type:
- Article
Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort study.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-59535-0
- By:
- Publication type:
- Article
Uptake of SARS-CoV-2 vaccination among structurally-marginalized people who use drugs in Vancouver, Canada.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-44069-8
- By:
- Publication type:
- Article
Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.775420
- By:
- Publication type:
- Article
Comprehensive Immune Profiling of a Kidney Transplant Recipient With Peri-Operative SARS-CoV-2 Infection: A Case Report.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.753558
- By:
- Publication type:
- Article
Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort Study.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 11, p. 2416, doi. 10.3390/v14112416
- By:
- Publication type:
- Article
2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN).
- Published in:
- Eurosurveillance (15607917), 2024, v. 29, n. 7, p. 1, doi. 10.2807/1560-7917.ES.2024.29.7.2400076
- By:
- Publication type:
- Article
Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23.
- Published in:
- Eurosurveillance (15607917), 2023, v. 28, n. 5, p. 10, doi. 10.2807/1560-7917.ES.2023.28.5.2300043
- By:
- Publication type:
- Article